Program Description

Join a presentation from one of your peers on the efficacy, safety, dosing, and administration of once-weekly Zepbound®. Learn about how to get appropriate patients started on this treatment. Attendees will have the opportunity to ask questions at the conclusion of the program. Refreshments will be provided.

This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.

Program Objectives

Upon completion of the program, participants will have learned the following about Zepbound:

• Mechanism of action.
• Clinical trial data, including efficacy and safety findings.
• Dosing and administration information.
• How to get appropriate patients started.

Registration is not necessary. For compliance reasons, the sponsor will close the doors 10 minutes after the presentation begins.

Discover how the RENOVATE Randomized Clinical Trial uses Bayesian modeling to compare nasal high flow therapy (NHF) and non-invasive ventilation (NIV) in five cohorts of acute respiratory failure. This session highlights key clinical outcomes and their impact on managing different respiratory phenotypes. Learn to distinguish between NHF and NIV in practice and gain practical strategies for integrating NHF into care protocols, including early initiation and weaning. Perfect for clinicians aiming to enhance patient outcomes with evidence-based respiratory therapy.

Join us for an engaging program that explores the practical implementation of all-nebulization strategies across diverse hospital environments. Expert speakers from leading institutions will share firsthand experiences, challenges, and successes in transitioning to nebulization-focused respiratory care.

Attendees will gain valuable insights into:

• The rationale behind adopting all-nebulization approaches.
• Key considerations for integration in different hospital settings.
• Real-world outcomes and lessons learned from early adopters.

Whether you are in clinical practice, hospital administration, or respiratory care leadership, this program offers actionable strategies to optimize patient care and operational efficiency.

Please join Rebecca Edwards, NP as they provide an overview of interstitial lung disease (ILD). During this symposium Ms. Edwards will review the signs and symptoms of ILD as well as emphasize the importance of nonpharmacological management and palliative care for these patients. Attendees will also have the chance to test their knowledge with quiz and polling questions throughout this interactive session.

This presentation is open to all AARC attendees. Onsite registration/admission will occur for conference registrants only at the symposium entrance on a first-come, first-serve basis.

This is a non-CME event and does not qualify for CME or CE credit.

Mechanical Ventilation Guided by Electrical Impedance Tomography: Individualized Care, A New Way Forward, presented by Dr. Marcelo Amato, MD, PhD.

A Multidisciplinary, Integrative Approach to the Clinical Practice, Education, and Quality Improvement of Mechanical Ventilation, presented by Dr. Richard Oeckler, MD, PhD, MS, FCCP.

Registration opens and breakfast will be served at 6:30 a.m.